8.71
price down icon3.44%   -0.31
 
loading
Schlusskurs vom Vortag:
$9.02
Offen:
$9.1
24-Stunden-Volumen:
3.91M
Relative Volume:
0.80
Marktkapitalisierung:
$2.49B
Einnahmen:
$6.41B
Nettoeinkommen (Verlust:
$1.30B
KGV:
1.7282
EPS:
5.04
Netto-Cashflow:
$646.00M
1W Leistung:
-9.18%
1M Leistung:
-31.09%
6M Leistung:
-45.70%
1J Leistung:
-57.53%
1-Tages-Spanne:
Value
$8.71
$9.13
1-Wochen-Bereich:
Value
$8.05
$9.41
52-Wochen-Spanne:
Value
$8.05
$23.10

Organon Co Stock (OGN) Company Profile

Name
Firmenname
Organon Co
Name
Telefon
551-430-6000
Name
Adresse
30 HUDSON STREET, JERSEY CITY
Name
Mitarbeiter
10,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
OGN's Discussions on Twitter

Vergleichen Sie OGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
OGN
Organon Co
8.71 2.49B 6.41B 1.30B 646.00M 5.04
Drug Manufacturers - General icon
LLY
Lilly Eli Co
734.57 739.39B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.22 375.64B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
184.60 351.09B 57.37B 4.20B 17.83B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
65.77 307.32B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
108.70 225.73B 53.22B 12.86B 14.85B 6.39

Organon Co Stock (OGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-02 Herabstufung Evercore ISI Outperform → In-line
2024-09-06 Herabstufung JP Morgan Neutral → Underweight
2023-11-03 Herabstufung Goldman Buy → Neutral
2023-09-21 Eingeleitet Barclays Overweight
2023-03-16 Eingeleitet Raymond James Outperform
2022-10-14 Herabstufung BofA Securities Neutral → Underperform
2022-09-06 Hochstufung Piper Sandler Neutral → Overweight
2022-08-05 Herabstufung BofA Securities Buy → Neutral
2022-04-27 Eingeleitet Goldman Buy
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-10-07 Eingeleitet Piper Sandler Neutral
2021-09-01 Eingeleitet BofA Securities Buy
2021-07-22 Eingeleitet Citigroup Buy
2021-06-15 Eingeleitet JP Morgan Neutral
2021-06-11 Eingeleitet Morgan Stanley Equal-Weight
2021-06-10 Eingeleitet Evercore ISI Outperform
Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

pulisher
10:40 AM

OGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire

10:40 AM
pulisher
May 09, 2025

OGN STOCK ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of an Ongoing Investigation - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 09, 2025
pulisher
May 08, 2025

ORGANON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Why Investors Shouldn't Be Surprised By Organon & Co.'s (NYSE:OGN) 30% Share Price Plunge - simplywall.st

May 08, 2025
pulisher
May 08, 2025

Levi & Korsinsky Announces an Investigation on Behalf of Organon & Co. (OGN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Organon: Management Slashes DividendThis Feels Disastrous (NYSE:OGN) - Seeking Alpha

May 08, 2025
pulisher
May 08, 2025

2025-05-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation | NYSE:OGN | Press Release - Stockhouse

May 08, 2025
pulisher
May 08, 2025

Ex-Dividend Reminder: H2O America, Exelon Corp and Organon & Co - Nasdaq

May 08, 2025
pulisher
May 08, 2025

EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug - marketscreener.com

May 08, 2025
pulisher
May 07, 2025

Organon Executives Make Bold Moves with Major Stock Purchases - TipRanks

May 07, 2025
pulisher
May 07, 2025

Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Insider Buying: Aaron Falcione Acquires Shares of Organon & Co (OGN) - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 07, 2025
pulisher
May 07, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Organon & Co. (OGN) - ACCESS Newswire

May 07, 2025
pulisher
May 07, 2025

Organon & Co. Executives Increase Their Holdings - TradingView

May 07, 2025
pulisher
May 07, 2025

Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN

May 07, 2025
pulisher
May 07, 2025

Levi & Korsinsky Reminds Organon & Co. Investors of the Ongoing Investigation into Potential Violations of Securities LawsOGN - ACCESS Newswire

May 07, 2025
pulisher
May 06, 2025

Top Executives Make Bold Moves with Major Organon Stock Purchases! - TipRanks

May 06, 2025
pulisher
May 06, 2025

Organon & Co. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsOGN - PR Newswire

May 06, 2025
pulisher
May 06, 2025

Did Organon & Co. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateOGN - ACCESS Newswire

May 06, 2025
pulisher
May 06, 2025

Organon downgraded to In Line from Outperform at Evercore ISI - MSN

May 06, 2025
pulisher
May 06, 2025

Organon & Co. Executives Make Significant Stock Purchases - TradingView

May 06, 2025
pulisher
May 06, 2025

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Organon & Co. (NYSE:OGN) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World

May 06, 2025
pulisher
May 06, 2025

Organon (OGN) Faces Price Target Cut Amid Dividend Adjustment - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Organon & Co. (NYSE:OGN) Given New $10.00 Price Target at Morgan Stanley - Defense World

May 06, 2025
pulisher
May 05, 2025

OGN Stock: Analyst Maintains Rating, Lowers Price Target to $10 | OGN Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Organon price target lowered to $10 from $15 at Morgan Stanley - TipRanks

May 05, 2025
pulisher
May 05, 2025

OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire

May 05, 2025
pulisher
May 05, 2025

Organon & Co. (NYSE:OGN) Cut to “Inline” at Evercore ISI - Defense World

May 05, 2025
pulisher
May 04, 2025

Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02 - simplywall.st

May 04, 2025
pulisher
May 04, 2025

Organon & Co. (NYSE:OGN) Sets New 52-Week Low – Here’s Why - Defense World

May 04, 2025
pulisher
May 03, 2025

Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025
pulisher
May 03, 2025

Brokerages Set Organon & Co. (NYSE:OGN) Target Price at $19.75 - Defense World

May 03, 2025
pulisher
May 02, 2025

SLQT INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into SelectQuote, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.

May 02, 2025
pulisher
May 02, 2025

OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Organon price target lowered to $10 from $11 at BofA - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion - MSN

May 02, 2025
pulisher
May 02, 2025

Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (OGN) - Seeking Alpha

May 02, 2025
pulisher
May 02, 2025

Organon & Co. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

Evercore ISI Downgrades Organon to In Line From Outperform - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - Defense World

May 02, 2025
pulisher
May 01, 2025

Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN

May 01, 2025
pulisher
May 01, 2025

Organon & Co. Earnings Call: Growth Amid Challenges - TipRanks

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Faces Downgrade Following Dividend Reduction | OGN Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon Co earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Faces Price Target Reduction and Dividend Cut | OG - GuruFocus

May 01, 2025

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$96.91
price down icon 1.27%
drug_manufacturers_general SNY
$49.90
price down icon 4.28%
drug_manufacturers_general PFE
$22.28
price down icon 3.00%
$265.86
price down icon 2.28%
drug_manufacturers_general MRK
$75.97
price down icon 2.16%
drug_manufacturers_general NVS
$108.70
price down icon 1.30%
Kapitalisierung:     |  Volumen (24h):